Tata Mutual Fund
← All mutual funds

Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option

Tata Mutual Fund · Index Funds · Direct · Growth

NAV · as of 11/09/2026

15.35

1D

-0.06%

1Y

+15.78%

Key stats

Expense ratio
0.55%
AUM
₹219.00 Cr
Launched
26/04/2024
Fund manager
Rakesh Prajapati; Nitin Sharma
Portfolio turnover
0.42%
Risk
Very High Risk
Min lump-sum
₹5,000
Min SIP
₹100/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

15.4915.1713/08/202611/09/2026
1W+0.62%
1M-0.07%
3M+8.34%
6M+22.80%
1Y+15.78%
MAX+52.23%

Top holdings

33 disclosed
  • 1.

    Laurus Labs Ltd

    Healthcare

    10.79%
  • 2.

    Lupin Ltd

    Healthcare

    8.96%
  • 3.

    Fortis Healthcare Ltd

    Healthcare

    7.52%
  • 4.

    Aurobindo Pharma Ltd

    Healthcare

    6.68%
  • 5.

    Alkem Laboratories Ltd

    Healthcare

    5.14%
  • 6.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    5.14%
  • 7.

    Biocon Ltd

    Healthcare

    4.64%
  • 8.

    Mankind Pharma Ltd

    Healthcare

    4.27%
  • 9.

    Ipca Laboratories Ltd

    Healthcare

    3.71%
  • 10.

    Krishna Institute of Medical Sciences Ltd

    Healthcare

    3.19%
  • 11.

    Aster DM Quality Care Ltd Ordinary Shares

    Healthcare

    3.18%
  • 12.

    Gland Pharma Ltd

    Healthcare

    3.05%
  • 13.

    Sai Life Sciences Ltd

    Healthcare

    2.77%
  • 14.

    Neuland Laboratories Ltd

    Healthcare

    2.51%
  • 15.

    Wockhardt Ltd

    Healthcare

    2.47%
  • 16.

    Acutaas Chemicals Ltd

    Basic Materials

    2.46%
  • 17.

    Dr. Lal PathLabs Ltd

    Healthcare

    2.27%
  • 18.

    Ajanta Pharma Ltd

    Healthcare

    2.23%
  • 19.

    Abbott India Ltd

    Healthcare

    2.21%
  • 20.

    Narayana Hrudayalaya Ltd

    Healthcare

    2.14%
  • 21.

    OneSource Specialty Pharma Ltd

    Healthcare

    1.95%
  • 22.

    Piramal Pharma Ltd

    Healthcare

    1.86%
  • 23.

    Global Health Ltd

    Healthcare

    1.84%
  • 24.

    Granules India Ltd

    Healthcare

    1.83%
  • 25.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    1.68%
  • 26.

    Natco Pharma Ltd

    Healthcare

    1.26%
  • 27.

    Syngene International Ltd

    Healthcare

    1.12%
  • 28.

    Pfizer Ltd

    Healthcare

    1.12%
  • 29.

    Cohance Lifesciences Ltd

    Healthcare

    1.06%
  • 30.

    Poly Medicure Ltd

    Healthcare

    0.99%
  • 31.

    (I) Treps

    0.10%
  • 32.

    Net Current Liabilities

    0.08%
  • 33.

    J.B. Chemicals & Pharmaceuticals Ltd

    -

Sector allocation

  • Healthcare97.53%
  • Basic Materials2.46%
  • Unclassified0.18%

Comparable peers

  • ICICI Prudential Nifty Pharma Index Growth Direct Plan

    ICICI Pru Nifty Pharma Index (G) · ₹147.90 Cr AUM

    1Y+21.17%
    3Y+20.55%
    -

  • Tata Nifty Midsmall Healthcare Index Growth Direct Plan

    Tata Nifty Midsmall Healthcare Index (G) · ₹219.00 Cr AUM

    1Y+16.46%
    3Y0.00%
    -

  • UTI Nifty 500 Value 50 Index Growth Direct Plan

    UTI Nifty 500 Value 50 Index (G) · ₹846.20 Cr AUM

    1Y+14.63%
    3Y+21.95%
    -

  • Motilal Oswal BSE Enhanced Value Index Growth Direct Plan

    Motilal Oswal BSE Enhanced Value Index (G) · ₹2.22 K Cr AUM

    1Y+10.12%
    3Y+20.25%
    -

  • ICICI Prudential Nifty Auto Index Growth Direct Plan

    ICICI Pru Nifty Auto Index (G) · ₹242.30 Cr AUM

    1Y+2.42%
    3Y+20.30%
    -

Investment objective

The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.

Scheme details

Scheme code
152564
Fund house
Tata Mutual Fund
Category
Open Ended
Type
Other Scheme
Sub-category
Index Funds
Plan
Direct
Return type
Growth
ISIN (Growth)
INF277KA1BG3
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page